Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 5, 2000, Pages 396-404

  Bogart, Laura M ^a,b   Kelly, Jeffrey A ^b   Catz, Sheryl L ^b   Sosman, James M ^c  

^a KENT STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adherence; Antiretroviral therapy; HAART; HIV treatment; Physician decision making

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ARTICLE; FEMALE; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENTAL DISEASE; OPPORTUNISTIC INFECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0034655045     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200004150-00006     Document Type: Article

References (43)

1. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA 1998;280:78-86.
2. U.S. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-I infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(RR-05):43-82.
3. Deeks SG, Loftus R, Cohen P, Chin S, Grant R. Incidence and predictors of virological failure of indinavir and/or ritonavir in an urban health clinic [abstract LB-02]. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997.
4. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
5. Bangsberg, D, Robertson M, Charlebois E, et al. Protease inhibitors (PI) in the HIV+ homeless and marginally housed (H/M): good adherence but rarely prescribed [abstract 389/32406]. Proceedings of the XII International Conference on AIDS, Geneva, 1998.
6. Bassetti S, Battegay M, Furrer H, et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? JAIDS J Acquir Immune Defic Syndr 1999;21:114-9.
7. Bing EG, Kilbourne AM, Brooks RA, Lazarus EF, Senak M. Protease inhibitor use among a community sample of people with HIV disease JAIDS J Acquir Immune Defic Syndr 1999;20:474-80.
8. Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients. J Int Assoc Phys AIDS Care 1998;4:32-5.
9. Heath K, Hogg RS, Singer J, Scheeler MT, O'Shaughnessy MV, Montaner JSG. Physician concurrence with primary care guidelines for persons living with HIV disease, Int J STD AIDS 1997; 8:609-13.
10. Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med 1994;154:1497-1504.
11. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. JAMA 1999;281:2305-15.
12. Sorvillo F, Kerndt P, Odem S, Castillon M, Carruth A, Contreras R. Use of protease inhibitors among persons with AIDS in Los Angeles County. AIDS Care 1999;11:147-55.
13. Ungvarski PJ, Rottner JE. Errors in prescribing HIV-1 protease inhibitors. J Assoc Nurses AIDS Care 1998;8:55-61.
14. Valian R, Moyle G, Reddy D. Physician decision-making in antiretroviral use. Br J Clin Pract 1994;48:243-5.
15. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-83.
16. Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA 1997;278:63-5.
17. Senak M. Predicting antiretroviral compliance: physicians' responsibilities versus patients' rights. J Int Assoc Phys AIDS Care 1997;June:45-8.
18. McFall SL, Wamecke RB, Kaluzny AD, Ford L. Practice setting and physician influences on judgments of colon cancer treatment by community physicians. Health Serv Res 1996;31:5-19.
19. McKinlay JB, Burns RB, Durante R, et al. Patient, physician, and presentational influences on clinical decision-making for breast cancer: results from a factorial experiment. J Eval Clin Pract 1997; 3:23-57.
20. Freiman MP. The rate of adoption of new procedures among physicians. Med Care 1985;23:939-45.
21. Colenda CC, Rapp SR, Leist JC, Poses RM. Clinical variables influencing treatment decisions for agitated dementia patients: survey of physician judgments. J Am Geriatr Soc 1996;44:1375-9.
22. Komaromy M, Lurie N, Osmond D, Vranizan K, Keane D, Bindman AB. Physician practice style and rates of hospitalization for chronic medical conditions. Med Care 1996;34:594-609.
23. Mangione TW. Mail surveys: improving the quality. Thousand Oaks, CA: Sage, 1995.
24. Yammarino FJ, Skinner SJ, Childers TL. Understanding mail survey response behavior. Publ Opin Q 1991;55:613-39.
25. Fox RJ, Crask MR, Kim J. Mail survey response rate: a metaanalysis of selected techniques for inducing response. Publ Opin Q 1988;52:467-91.
26. Berry SH, Kanouse DE. Physician response to a mailed survey: an experiment in timing of payment. Publ Opin Q 1987;51:102-14.
27. Bonito AJ, Samsa GP, Akin DR, Matchar DB. Use of a nonmonetary incentive to improve physician responses to a mail survey. Acad Med 1997;72:73.
28. Yu J, Cooper H. A quantitative review of research design effects on response rates to questionnaires. J Market Res 1983;20:36-44.
29. Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men's shelter. Am J Public Health 1993;83:568-70.
30. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev 1997;17:259-69.
31. Leigh BC, Stall R. Substance use and risky sexual behavior for HIV: issues in methodology, interpretation, and prevention. Am Psychol 1993;48:1035-45.
32. Davis MS. Variations in patients' compliance with doctors' orders: analysis of congruence between survey responses and results of empirical investigations. J Med Educ 1966;41:1037-48.
33. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6:592-9.
34. Miller L, Liu H, Beck K. Providers' estimates of adherence overestimate reports from medication event monitoring system (MEMS) for patients on protease inhibitors (PIs) [abstract 97]. Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 1999.
35. Paterson D, Swindells S, Mohr J, et al. How much adherence is enough: a prospective study of adherence to protease inhibitor therapy using MEMS caps [abstract 92]. Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 1999.
36. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33.
37. Chesney MA, Ickovics J, Hecht F M, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999;13:S271-8.
38. Kalichman SC, Ramachandran B, Catz SL. Adherence to combination antiretroviral therapies in HIV patients of low health literacy J Gen intern Med 1999;14:267-73.
39. Weidle PJ, Ganea CE, Ernst J, McGowan J, Irwin KL, Holberg SD. Multiple reasons for nonadherence to antiretroviral medications in an inner-city minority population: need for a multi-faceted approach to improve adherence [abstract 32360]. Proceedings of the XII International Conference on AIDS, Geneva, 1998.
40. Broers B, Morabia, A, Hirschel B. A cohort study of drug user's compliance with zidovudine treatment. Arch Intern Med 1994;154: 1121-7.
41. Sherbourne CD, Hays RD, Ordway L, et al. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med 1992;15:447-68.
42. El-Sadr W, Medard F, Barthaud V. Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993. Am J Public Health 1996;86:1146-9.
43. Kemp R. Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998;172:413-9.